Amgen issues $3B in senior notes across three tranches with maturities 2029-2053

AMGEN INC

Issued $1.25B of 4.050% Senior Notes due 2029, $750M of 4.200% due 2033, and $1.0B of 4.875% due 2053.
Net proceeds approximately $2.976B after underwriters' discounts and estimated offering expenses.
Notes are senior unsecured and rank equally with other senior unsecured indebtedness of the company.
Interest payable semi-annually; first payment Feb 18, 2023 (2029 notes) and March 1, 2023 (2033 and 2053 notes).
Change-in-control triggering event allows holders to require repurchase at 101% of principal plus accrued interest.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.